PRTA
Prothena Corporation PLC
Price:  
7.43 
USD
Volume:  
1,656,848.00
Ireland | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PRTA Relative Valuation

-326.3%
Upside

As of 2025-05-12, the Relative Valuation of Prothena Corporation PLC (PRTA) is (16.81) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.43 USD, the upside of Prothena Corporation PLC based on Relative Valuation is -326.3%.

The range of the Relative Valuation is (7.13) - (25.68) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 2.9x - 11.3x 7.1x
Forward P/E multiples 3.1x - 12.3x 7.7x
Fair Price (7.13) - (25.68) (16.81)
Upside -196.0% - -445.6% -326.3%
7.43 USD
Stock Price
(16.81) USD
Fair Price

PRTA Relative Valuation - Historical P/E Data

Date P/E
2025-05-07 -3.21
2025-05-06 -3.23
2025-05-05 -3.56
2025-05-02 -3.74
2025-05-01 -3.84
2025-04-30 -4.05
2025-04-29 -4.26
2025-04-28 -4.25
2025-04-25 -4.27
2025-04-24 -4.25
2025-04-23 -4.22
2025-04-22 -4.20
2025-04-21 -4.09
2025-04-17 -4.05
2025-04-16 -4.08
2025-04-15 -4.22
2025-04-14 -4.37
2025-04-11 -4.50
2025-04-10 -4.26
2025-04-09 -4.52
2025-04-08 -4.61
2025-04-07 -4.77
2025-04-04 -4.78
2025-04-03 -4.98
2025-04-02 -5.34
2025-04-01 -5.17
2025-03-31 -5.45
2025-03-28 -5.78
2025-03-27 -5.73
2025-03-26 -5.88
2025-03-25 -5.57
2025-03-24 -5.87
2025-03-21 -5.71
2025-03-20 -5.66
2025-03-19 -5.67
2025-03-18 -5.65
2025-03-17 -6.05
2025-03-14 -6.05
2025-03-13 -6.19
2025-03-12 -6.10
2025-03-11 -6.05
2025-03-10 -6.42
2025-03-07 -6.72
2025-03-06 -6.66
2025-03-05 -6.58
2025-03-04 -6.63
2025-03-03 -6.31
2025-02-28 -6.96
2025-02-27 -6.66
2025-02-26 -6.40